1Karina LM, Peter P. Variable receptors controlling activation and inhibition of NK cells[J]. Cur Opin in lmmuno1,2002,14:615-621.
2Janice MM, Anthony MB, Aron EL. NK cell receptors in antiviral immunity[J]. Cur Opin in Immunol ,2002 ,14 :509-516.
3Lopez-Botet M, Llano M, Ortega M. Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: a paradigm of host-pathogen adaptation [ J ]. Immunol Rev, 2001,181 :193-202.
4Odeberg J, Cerbonic BH, Karre K, et al. Human cytomegalovirus(HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class Ihomologue, UL18[ J ]. Stand J Immunol,2002,55 (2) : 149-161.
5Braud VM, Tomasec P, Wilkinson GW. Viral evasion of natural killer cells during human cytomegalovirus infection[J]. Curt Top Microbiol Immunol, 2002,269:117-129.
7Moretta A, Bottino C, Vitah M,et al. Activiating receptors and coreceptors involved in human natural killer cell-mediated cytolysis[ J ]. Annu Rev Immunol,2001,19 : 197-223.
8Vales-Gomez M, Reyburn HT, Erskine RA, et al. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2A and the activiating receptor CD94/NKG2C to HLAE[J].EMBO J, 1999,18:4250-4260.
9Tomasec P, Braud VM. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40[J].Science,2000, 287(5455) :1031-1033.
10Ulbrecht M, Martinozzi S. Cutting edge :the human cyotmegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis[J]. J lmmunol, 2000,164(10) :5019-5022.